Find clinical trials for M.D. Anderson. Search for M.D. Anderson clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 530
Managing Agitated Delirium With Neuroleptics and Anti-Epileptics as a Neuroleptic Sparing Strategy
for
Delirium, Epileptics, Neuroleptics
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05431595
Phase2, Phase3, Recruiting
High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
for
Splenomegaly, Myelofibrosis
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT06345495
Phase2, Recruiting
Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma
for
Renal Cell Carcinoma
Location: Boston MA, Ann Arbor MI, Houston TX, Dallas TX,
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06053658
Phase2, Recruiting
Combination Therapy for Cancer Related Fatigue in Patients With Metastatic Cancers
for
Metastatic Cancers, Fatigue
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06085716
Phase2, Phase3, Recruiting
Minimally-invasive Stabilization of Pelvic Metastases With Photodynamic Nails: A Multi-center Prospective Study of Functional Outcome
for
Pelvic Metastasis
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06083896
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring
for
Biochemically Recurrent Prostate Carcinoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Male
Age: 18+
Code: NCT05054296
Phase2, Recruiting
3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial
for
Head and Neck Squamous Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05674396
Phase2, Recruiting
Patient-Specific Computational Walking Models in Improving Surgical and Rehabilitation Treatment in Patients With Pelvic Sarcomas
for
Pelvic Sarcoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05054335
Recruiting
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Peripheral Nerve Stimulation of Genicular Nerves Versus Conventional Therapy With Intra-articular Steroid Injection for Chronic Knee Pain: A Prospective, Randomized Pilot Study
for
Peripheral Nerve Stimulation, Genicular Nerves,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06004882
Recruiting
Molecular Epidemiology of Biliary Tree Cancers
for
Cholangiocarcinoma, Malignant Digestive System Neoplasm
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 0+
Code: NCT05179486
Recruiting
Phase I Study of HC-7366 for Acute Myeloid Leukemia
for
Acute Myeloid Leukemia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06285890
Phase1, Recruiting
Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study
for
Colorectal Adenocarcinoma, Stage I Colorectal Cancer AJCC v8,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT04739072
Recruiting
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
for
Ovarian Cancer, Breast Cancer, Colorectal Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 18+
Code: NCT05649072
Recruiting
Molecular Basis for Variations in Hereditary Colorectal Cancer Syndromes
for
Hereditary Colorectal Cancer Syndrome
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT02863172
Recruiting
Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
Decitabine Alone or in Combination With Venetoclax, Gilteritinib, Enasidenib, or Ivosidenib as Maintenance Therapy for the Treatment of Acute Myeloid Leukemia in Remission
for
Acute Myeloid Leukemia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05010772
Phase1, Recruiting
A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients
for
Pulmonary Hemorrhage, Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05053867
Phase3, Recruiting
Phase I/II Study of Engineered T Cell Receptor-Modified NK Cells Targeting PRAME in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Myeloid Malignancies